Currently the U.S and the world face an increasingly dangerous health issue of severe blood shortages which will only get worse in the future. One of the big reasons is because blood gets severely damaged from a condition known as Red Blood Cell Storage Lesion ( RBCSL). The RBCSL decreases shelf life of blood, decreases efficiency of blood cells and increases side effects of transfusion.We have invented a technology that decreases the damage that RBCSL does. It does this by removing specific loose components of damaged blood within the unit of donated red blood cells that cause the condition. It will be used post processing in blood centers and before blood transfusions within hospitals.It is an integrative device that can fit in with today's current standards.